Ryan B. Corcoran

Massachusetts General Hospital

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

3in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Data from Results and Molecular Correlates from a Pilot Study of Neoadjuvant Induction FOLFIRINOX Followed by Chemoradiation and Surgery for Gastroesophageal Adenocarcinomas

(2023)10.1158/1078-0432.c.6531324

Top 100%

0DataRank

Top 100%0 citations

Jeffrey W. Clark, Christine E. Eyler, Mari Mino–Kenudson, Samuel J. Klempner, Jill N. Allen +20 more

Papers

Driven by 35 papers — median percentile 0. Top paper: “Combined PD-1, BRAF and MEK inhibition in BRAFV600E colorectal cancer: a phase 2 trial”.

Combined PD-1, BRAF and MEK inhibition in BRAFV600E colorectal cancer: a phase 2 trial

Nature Medicine(2023)10.1038/s41591-022-02181-8

N/A

4.9DataRank · unranked

192 citations

Jonathan Chen, Sherry Chao, Karin Pelka, Marios Giannakis, Julian M. Hess +40 more

Targeting TBK1 to overcome resistance to cancer immunotherapy

Nature(2023)10.1038/s41586-023-05704-6

N/A

4.0DataRank · unranked

171 citations

Or‐Yam Revach, Seth Anderson, Emily Kessler, Clara Wolfe, Anne Jenney +54 more

Ultrasensitive Detection of Circulating LINE-1 ORF1p as a Specific Multicancer Biomarker

Cancer Discovery(2023)10.1158/2159-8290.cd-23-0313

N/A

1.7DataRank · unranked

85 citations

Connie Wu, Peter C. Fridy, Stephanie J. Zhang, Yasmeen Senussi, Justina C. Wolters +54 more

Sotorasib Is a Pan- RAS G12C Inhibitor Capable of Driving Clinical Response in NRAS G12C Cancers

Cancer Discovery(2024)10.1158/2159-8290.cd-23-1138

N/A

1.3DataRank · unranked

43 citations

Noritaka Tanaka, Ferran Fece de la Cruz, Kevin S. Kapner, Michael H. Rosenthal, Bryanna L. Norden +8 more

Spatially organized multicellular immune hubs in human colorectal cancer

Cell(2021)10.1016/j.cell.2021.08.003

N/A

1.0DataRank · unranked

787 citations

Matan Hofree, Siranush Sarkizova, Joshua D. Pirl, Vjola Jorgji, Alborz Bejnood +73 more

Results and Molecular Correlates from a Pilot Study of Neoadjuvant Induction FOLFIRINOX Followed by Chemoradiation and Surgery for Gastroesophageal Adenocarcinomas

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-0331

N/A

0.824DataRank · unranked

13 citations

Jeffrey W. Clark, Christine E. Eyler, Mari Mino–Kenudson, Samuel J. Klempner, Jill N. Allen +20 more

KRASG12C-independent feedback activation of wild-type RAS constrains KRASG12C inhibitor efficacy

Cell Reports(2022)10.1016/j.celrep.2022.110993

N/A

0.769DataRank · unranked

168 citations

Oluwadara Coker, Alexey V. Sorokin, Katerina A. Fella, Haley Barnes, Edmond Wong +7 more

Quantification of ongoing APOBEC3A activity in tumor cells by monitoring RNA editing at hotspots

Nature Communications(2020)10.1038/s41467-020-16802-8

N/A

0.722DataRank · unranked

122 citations

Danae Bowen, Adam Langenbucher, Greg Park, Karmen Aguirre, Ryan B. Corcoran +5 more

FGFR2 Extracellular Domain In-Frame Deletions Are Therapeutically Targetable Genomic Alterations That Function as Oncogenic Drivers in Cholangiocarcinoma

Cancer Discovery(2021)10.1158/2159-8290.cd-20-1669

N/A

0.705DataRank · unranked

109 citations

Srivatsan Raghavan, Qibiao Wu, Yvonne Y. Li, Liam F. Spurr, Hersh Gupta +35 more

Reverse Transcriptase Inhibition Disrupts Repeat Element Life Cycle in Colorectal Cancer

Cancer Discovery(2022)10.1158/2159-8290.cd-21-1117

N/A

0.617DataRank · unranked

60 citations

Aparna R. Parikh, Alexander Solovyov, Eunae You, Anupriya S. Kulkarni, Chong Chu +44 more

TOP1 Mutations and Cross-Resistance to Antibody–Drug Conjugates in Patients with Metastatic Breast Cancer

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-2771

N/A

0.574DataRank · unranked

45 citations

Bogang Wu, Haley Barnes, Arielle J. Medford, Bryanna L. Norden, Annika Putur +16 more

Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid Tumors

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-3135

N/A

0.546DataRank · unranked

37 citations

T. Khanh, Jeong Eun Kim, James M. Cleary, Aparna R. Parikh, Oladapo Yeku +26 more

Phase 1/2 trial of encorafenib, cetuximab, and nivolumab in microsatellite stable BRAFV600E metastatic colorectal cancer

Cancer Cell(2025)10.1016/j.ccell.2025.08.002

N/A

0.477DataRank · unranked

23 citations

Christine M. Parseghian, Vahid Bahrambeigi, Nourhan Abdelfattah, Lianchun Xiao, Anjali Agrawal +28 more

Multicellular immune hubs and their organization in MMRd and MMRp colorectal cancer

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.01.30.426796

N/A

0.297DataRank · unranked

4 citations

Matan Hofree, Jonathan Chen, Siranush Sarkizova, Joshua D. Pirl, Vjola Jorgji +71 more

Results and molecular correlates from a pilot study of neoadjuvant induction FOLFIRINOX followed by chemoradiation and surgery for gastroesophageal adenocarcinomas

Research Square(2020)10.21203/rs.3.rs-92371/v1

N/A

0.104DataRank · unranked

1 citations

Jeffrey Clark, Christine E. Eyler, Mari Mino–Kenudson, Samuel J. Klempner, Jill N. Allen +20 more

Data from Reverse Transcriptase Inhibition Disrupts Repeat Element Life Cycle in Colorectal Cancer

(2023)10.1158/2159-8290.c.6549619.v1

N/A

0DataRank · unranked

0 citations

Aparna R. Parikh, Alexander Solovyov, Eunae You, Anupriya S. Kulkarni, Chong Nam Chu +44 more

The Irreversible FGFR Inhibitor KIN-3248 Overcomes FGFR2 Kinase Domain Mutations

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-3588

N/A

0DataRank · unranked

16 citations

Qibiao Wu, Haley Ellis, Yuanli Zhen, Bryanna L. Norden, Ryan B. Corcoran +11 more

Minimal Residual Disease using a Plasma-Only Circulating Tumor DNA Assay to Predict Recurrence of Metastatic Colorectal Cancer Following Curative Intent Treatment

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-3660

N/A

0DataRank · unranked

16 citations

Bryant H. Chee, Jill Tsai, Thereasa A. Rich, Kristin S. Price, Sonia Patel +13 more

A unique interplay of access and selection shapes peritoneal metastasis evolution in colorectal cancer

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.09.25.614736

N/A

0DataRank · unranked

3 citations

Alexander N. Gorelick, Wei‐Ting Hung, David Cheek, Emre Küçükköse, I‐Hsiu Lee +19 more

Genomic landscape of clinically acquired resistance alterations in patients treated with KRASG12C inhibitors

Annals of Oncology(2025)10.1016/j.annonc.2025.01.020

N/A

0DataRank · unranked

51 citations

Ferran Fece de la Cruz, W. Marston Linehan, Christine M. Parseghian, Jonathan Kim, Hiroyuki Matsubara +19 more

MAPK Pathway Mutations Emerge in Mutant IDH1 Inhibitor–Resistant Cholangiocarcinoma and Attenuate the IFN Response

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-25-3284

N/A

0DataRank · unranked

3 citations

Hatice D. Saatcioglu, Haley Ellis, Elia Aguado-Fraile, Qin Xu, Hiroshi Kondo +20 more

Serial ctDNA Monitoring to Predict Response to Systemic Therapy in Metastatic Gastrointestinal Cancers

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3467

N/A

0DataRank · unranked

143 citations

Amikasra Mojtahed, Jaime L. Schneider, Katie Kanter, Emily E. Van Seventer, Isobel J. Fetter +25 more

Clinical Acquired Resistance to KRASG12C Inhibition through a Novel KRAS Switch-II Pocket Mutation and Polyclonal Alterations Converging on RAS–MAPK Reactivation

Cancer Discovery(2021)10.1158/2159-8290.cd-21-0365

N/A

0DataRank · unranked

520 citations

W. Marston Linehan, Chendi Li, Meagan B. Ryan, Junbing Zhang, Lesli A. Kiedrowski +15 more

Cell-Free HPV DNA Provides an Accurate and Rapid Diagnosis of HPV-Associated Head and Neck Cancer

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-3151

N/A

0DataRank · unranked

114 citations

Connor J. O'Boyle, Shohreh Varmeh, Natalia Queenan, Alexa Michel, Jarrod Stein +22 more

Cell‐free human papillomavirus DNA kinetics after surgery for human papillomavirus–associated oropharyngeal cancer

Cancer(2022)10.1002/cncr.34109

N/A

0DataRank · unranked

83 citations

Giulia Siravegna, Shohreh Varmeh, Natalia Queenan, Alexa Michel, Kim Chang Sing Pang +19 more

Chromatin-bound RB targets promoters, enhancers, and CTCF-bound loci and is redistributed by cell-cycle progression

Molecular Cell(2022)10.1016/j.molcel.2022.07.014

N/A

0DataRank · unranked

30 citations

Hanjun Lee, Purva Rumde, Gaylor Boulay, Robert Morris, Gabriel Golczer +10 more

Landscape of Clinical Resistance Mechanisms to FGFR Inhibitors in FGFR2-Altered Cholangiocarcinoma

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1317

N/A

0DataRank · unranked

80 citations

Haley Ellis, Giulia Siravegna, Alexa Michel, Bryanna L. Norden, Ferran Fece de la Cruz +7 more

Allosteric PI3Kα Inhibition Overcomes On-target Resistance to Orthosteric Inhibitors Mediated by Secondary PIK3CA Mutations

Cancer Discovery(2023)10.1158/2159-8290.cd-23-0704

N/A

0DataRank · unranked

61 citations

Ferran Fece de la Cruz, Elizabeth E. Martin, Bryanna L. Norden, Nicholas Chevalier, Allison M. Kehlmann +26 more

664P Final results of a phase I/II study of combined BCL-xL and MEK inhibition with navitoclax and trametinib in KRAS or NRAS mutant advanced solid tumors

Annals of Oncology(2023)10.1016/j.annonc.2023.09.1850

N/A

0DataRank · unranked

1 citations

T. Khanh, James M. Cleary, Aparna R. Parikh, Oladapo Yeku, Colin D. Weekes +13 more

Data from Results and Molecular Correlates from a Pilot Study of Neoadjuvant Induction FOLFIRINOX Followed by Chemoradiation and Surgery for Gastroesophageal Adenocarcinomas

(2023)10.1158/1078-0432.c.6531324

Top 100%

0DataRank

Top 100%0 citations

Jeffrey W. Clark, Christine E. Eyler, Mari Mino–Kenudson, Samuel J. Klempner, Jill N. Allen +20 more

Data from Results and Molecular Correlates from a Pilot Study of Neoadjuvant Induction FOLFIRINOX Followed by Chemoradiation and Surgery for Gastroesophageal Adenocarcinomas

(2023)10.1158/1078-0432.c.6531324.v1

Top 100%

0DataRank

Top 100%0 citations

Jeffrey W. Clark, Christine E. Eyler, Mari Mino–Kenudson, Samuel J. Klempner, Jill N. Allen +20 more

Data from Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal Cancer

(2023)10.1158/1078-0432.c.6530634

N/A

0DataRank · unranked

0 citations

Emily E. Van Seventer, Giulia Siravegna, Anna Hartwig, Ariel Jaimovich, Yupeng He +38 more

Data from Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal Cancer

(2023)10.1158/1078-0432.c.6530634.v1

N/A

0DataRank · unranked

0 citations

Emily E. Van Seventer, Giulia Siravegna, Anna Hartwig, Ariel Jaimovich, Yupeng He +38 more

Data from Vertical Pathway Inhibition Overcomes Adaptive Feedback Resistance to KRASG12C Inhibition

(2023)10.1158/1078-0432.c.6529850.v1

N/A

0DataRank · unranked

0 citations

Ferran Fece de la Cruz, Sarah Phat, David T. Myers, Edmond Wong, Heather A. Shahzade +3 more

Data from Vertical Pathway Inhibition Overcomes Adaptive Feedback Resistance to KRASG12C Inhibition

(2023)10.1158/1078-0432.c.6529850

N/A

0DataRank · unranked

0 citations

Ferran Fece de la Cruz, Sarah Phat, David T. Myers, Edmond Wong, Heather A. Shahzade +3 more

Ryan B. Corcoran

Indexed papers

Top data-sharing exemplar

Papers